FDA Inspection 1232973 — Kaiser Permanente Of The Mid-Atlantic States IRB #7
The FDA completed an inspection of Kaiser Permanente Of The Mid-Atlantic States IRB #7 on Feb 26, 2024 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rockville, MD (United States)
Additional Details
IRB